News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Fed Nomination Gains Traction; EIA Boosts Oil Forecasts; Geopolitical Easing Calms Oil (March 11, 2026)2Oracle FY2026 Q3 Earnings Beat Expectations: Revenue and EPS Both Surge, AI-Driven Cloud Growth Hits 44%, Raises Next Fiscal Year Guidance!3Bitcoin permabull Arthur Hayes says he wouldn't bet $1 on BTC right now
5 Thought-Provoking Analyst Inquiries From Cracker Barrel’s Fourth Quarter Earnings Discussion
101 finance·2026/03/11 12:15
Bond Yields Surge Amid Climbing Oil Prices and Ongoing Middle East Conflict Uncertainty
101 finance·2026/03/11 12:15
Zoox and Uber tie up to deploy robotaxis on ride-hailing network
101 finance·2026/03/11 12:15
Price declines for gold and silver; U.S. CPI report upcoming
101 finance·2026/03/11 12:09
Is AGTHX (American Funds Growth Fund of America A) Currently a Top Choice Among Mutual Funds?
101 finance·2026/03/11 12:06
Starknet Unveils STRK20 for Compliant Private Asset Deals
Cryptotale·2026/03/11 12:03
FTSE 100’s Turbulent March: Energy Industry Highlights Disparity in Geopolitical Predictions
101 finance·2026/03/11 11:54
Wall Street Investors Search for a Market Floor Amid Ongoing Conflict Turmoil
101 finance·2026/03/11 11:42
Flash
12:18
Strive has officially announced an increase in the dividend rate of its Sata Series Preferred Shares to 12.75%.At the same time, the company's board of directors has decided to distribute a dividend of $1.0625 per share, which is expected to be paid to eligible shareholders on April 15, 2026. The increase in the dividend rate and the distribution of dividends reflect the company's solid financial position and ongoing commitment to shareholder returns. Investors should pay attention to the relevant equity registration date to confirm their eligibility for receiving dividends.
12:16
Tempest Therapeutics Inc. (referred to as Tempest) recently disclosed a strategic collaboration regarding its core candidate drug Tpst-2003.This important initiative aims to fully prepare for the launch of a registered study in the United States in 2026. The collaboration will integrate multiple resources to accelerate the clinical development process of the drug.
12:16
Renewal Fuels, Inc. (OTC: RNWF) announces the official appointment of Sebastian E. Hoyos as Chief Revenue Officer during its operation under the American Fusion brand.This key personnel appointment is intended to enable them to fully lead and drive the implementation of Texatron platform's commercialization strategy.
Trending news
MoreRenewal Fuels, Inc. (OTC: RNWF) announces the official appointment of Sebastian E. Hoyos as Chief Revenue Officer during its operation under the American Fusion brand.
Activist investment firm Starboard recently released a report stating that the "structural advantage omnichannel model" built by CarMax has not yet been fully reflected in its current financial performance.
News